Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
- Conditions
- Neuroendocrine TumorsCarcinoid Tumors
- Interventions
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2023-03-06
- Target Recruit Count
- 29
- Registration Number
- NCT01253161
- Locations
- 🇺🇸
Stanford Cancer Institute, Stanford, California, United States
🇺🇸H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
- Conditions
- Cholangiocarcinoma
- Interventions
- Device: TheraSphere® Yttrium-90 (Y-90) Microspheres
- First Posted Date
- 2010-12-03
- Last Posted Date
- 2017-03-22
- Target Recruit Count
- 25
- Registration Number
- NCT01253148
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Gem-TABS in Unresectable Pancreatic Carcinoma
- Conditions
- Pancreatic Cancer
- Interventions
- Drug: Sodium bicarbonate (g/kg/day)
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2017-02-23
- Target Recruit Count
- 8
- Registration Number
- NCT01198821
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma
- Conditions
- Melanoma (Skin)
- Interventions
- Biological: NY-ESO-1 157-165 (165V)Drug: Montanide ISA 51 vegetable grade (VG)Procedure: Apheresis Procedure
- First Posted Date
- 2010-08-06
- Last Posted Date
- 2023-07-19
- Target Recruit Count
- 73
- Registration Number
- NCT01176474
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558
- Conditions
- Melanoma (Skin)
- Interventions
- First Posted Date
- 2010-08-06
- Last Posted Date
- 2023-01-18
- Target Recruit Count
- 127
- Registration Number
- NCT01176461
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression Fractures
- Conditions
- Multiple Myeloma
- Interventions
- Procedure: Vertebral Augmentation with Balloon KyphoplastyOther: Non-surgical Treatment
FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer
Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS
- Conditions
- Myelodysplastic SyndromeMDS
- Interventions
- First Posted Date
- 2010-05-28
- Last Posted Date
- 2019-12-17
- Target Recruit Count
- 28
- Registration Number
- NCT01133275
- Locations
- 🇺🇸
University of Florida Shands Cancer Center, Gainesville, Florida, United States
🇺🇸H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease (GVHD)
- First Posted Date
- 2010-04-27
- Last Posted Date
- 2018-05-15
- Target Recruit Count
- 22
- Registration Number
- NCT01111526
- Locations
- 🇺🇸
H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
- First Posted Date
- 2010-03-23
- Last Posted Date
- 2013-12-16
- Target Recruit Count
- 1
- Registration Number
- NCT01090973
- Locations
- 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States